147 related articles for article (PubMed ID: 15615705)
1. CLAC binds to amyloid beta peptides through the positively charged amino acid cluster within the collagenous domain 1 and inhibits formation of amyloid fibrils.
Osada Y; Hashimoto T; Nishimura A; Matsuo Y; Wakabayashi T; Iwatsubo T
J Biol Chem; 2005 Mar; 280(9):8596-605. PubMed ID: 15615705
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Alzheimer's disease-associated CLAC protein and identification of an amyloid beta-peptide-binding site.
Söderberg L; Kakuyama H; Möller A; Ito A; Winblad B; Tjernberg LO; Näslund J
J Biol Chem; 2005 Jan; 280(2):1007-15. PubMed ID: 15522881
[TBL] [Abstract][Full Text] [Related]
3. Collagenous Alzheimer amyloid plaque component assembles amyloid fibrils into protease resistant aggregates.
Söderberg L; Dahlqvist C; Kakuyama H; Thyberg J; Ito A; Winblad B; Näslund J; Tjernberg LO
FEBS J; 2005 May; 272(9):2231-6. PubMed ID: 15853808
[TBL] [Abstract][Full Text] [Related]
4. CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV.
Hashimoto T; Wakabayashi T; Watanabe A; Kowa H; Hosoda R; Nakamura A; Kanazawa I; Arai T; Takio K; Mann DM; Iwatsubo T
EMBO J; 2002 Apr; 21(7):1524-34. PubMed ID: 11927537
[TBL] [Abstract][Full Text] [Related]
5. CLAC binds to aggregated Abeta and Abeta fragments, and attenuates fibril elongation.
Kakuyama H; Söderberg L; Horigome K; Winblad B; Dahlqvist C; Näslund J; Tjernberg LO
Biochemistry; 2005 Nov; 44(47):15602-9. PubMed ID: 16300410
[TBL] [Abstract][Full Text] [Related]
6. Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
Kowa H; Sakakura T; Matsuura Y; Wakabayashi T; Mann DM; Duff K; Tsuji S; Hashimoto T; Iwatsubo T
Am J Pathol; 2004 Jul; 165(1):273-81. PubMed ID: 15215182
[TBL] [Abstract][Full Text] [Related]
7. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques.
Hashimoto T; Fujii D; Naka Y; Kashiwagi-Hakozaki M; Matsuo Y; Matsuura Y; Wakabayashi T; Iwatsubo T
Acta Neuropathol Commun; 2020 Dec; 8(1):212. PubMed ID: 33287899
[TBL] [Abstract][Full Text] [Related]
8. Scanning cysteine mutagenesis analysis of Abeta-(1-40) amyloid fibrils.
Shivaprasad S; Wetzel R
J Biol Chem; 2006 Jan; 281(2):993-1000. PubMed ID: 16263715
[TBL] [Abstract][Full Text] [Related]
9. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
10. Seeding specificity in amyloid growth induced by heterologous fibrils.
O'Nuallain B; Williams AD; Westermark P; Wetzel R
J Biol Chem; 2004 Apr; 279(17):17490-9. PubMed ID: 14752113
[TBL] [Abstract][Full Text] [Related]
11. Walnut extract inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils.
Chauhan N; Wang KC; Wegiel J; Malik MN
Curr Alzheimer Res; 2004 Aug; 1(3):183-8. PubMed ID: 15975066
[TBL] [Abstract][Full Text] [Related]
12. Localization of a fibrillar amyloid beta-protein binding domain on its precursor.
Van Nostrand WE; Melchor JP; Keane DM; Saporito-Irwin SM; Romanov G; Davis J; Xu F
J Biol Chem; 2002 Sep; 277(39):36392-8. PubMed ID: 12107175
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
15. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species.
Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D
J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062
[TBL] [Abstract][Full Text] [Related]
16. Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers.
Ahn JH; Hu Y; Hernandez M; Kim JR
Biochem Biophys Res Commun; 2011 Oct; 414(1):79-83. PubMed ID: 21945434
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.
Verdier Y; Zarándi M; Penke B
J Pept Sci; 2004 May; 10(5):229-48. PubMed ID: 15160835
[TBL] [Abstract][Full Text] [Related]
18. Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions.
McLaurin J; Fraser PE
Eur J Biochem; 2000 Nov; 267(21):6353-61. PubMed ID: 11029577
[TBL] [Abstract][Full Text] [Related]
19. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
Nichols MR; Moss MA; Reed DK; Cratic-McDaniel S; Hoh JH; Rosenberry TL
J Biol Chem; 2005 Jan; 280(4):2471-80. PubMed ID: 15528204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
